325 related articles for article (PubMed ID: 1846368)
1. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
Ploug M; Rønne E; Behrendt N; Jensen AL; Blasi F; Danø K
J Biol Chem; 1991 Jan; 266(3):1926-33. PubMed ID: 1846368
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator.
Møller LB; Ploug M; Blasi F
Eur J Biochem; 1992 Sep; 208(2):493-500. PubMed ID: 1325912
[TBL] [Abstract][Full Text] [Related]
3. N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand.
Møller LB; Pöllänen J; Rønne E; Pedersen N; Blasi F
J Biol Chem; 1993 May; 268(15):11152-9. PubMed ID: 8388383
[TBL] [Abstract][Full Text] [Related]
4. A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria.
Ploug M; Eriksen J; Plesner T; Hansen NE; Danø K
Eur J Biochem; 1992 Sep; 208(2):397-404. PubMed ID: 1325906
[TBL] [Abstract][Full Text] [Related]
5. Evidence for carboxyl-terminal processing and glycolipid-anchoring of human carcinoembryonic antigen.
Takami N; Misumi Y; Kuroki M; Matsuoka Y; Ikehara Y
J Biol Chem; 1988 Sep; 263(25):12716-20. PubMed ID: 2842340
[TBL] [Abstract][Full Text] [Related]
6. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
Wolf BB; Gibson CA; Kapur V; Hussaini IM; Musser JM; Gonias SL
J Biol Chem; 1994 Dec; 269(48):30682-7. PubMed ID: 7982988
[TBL] [Abstract][Full Text] [Related]
7. Soluble urokinase receptor from fibrosarcoma HT-1080 cells.
Lau HK; Kim M
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):473-8. PubMed ID: 7841301
[TBL] [Abstract][Full Text] [Related]
8. Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells.
Del Rosso M; Pedersen N; Fibbi G; Pucci M; Dini G; Anichini E; Blasi F
Exp Cell Res; 1992 Dec; 203(2):427-34. PubMed ID: 1333982
[TBL] [Abstract][Full Text] [Related]
9. A surface antigen of Giardia lamblia with a glycosylphosphatidylinositol anchor.
Das S; Traynor-Kaplan A; Reiner DS; Meng TC; Gillin FD
J Biol Chem; 1991 Nov; 266(31):21318-25. PubMed ID: 1657957
[TBL] [Abstract][Full Text] [Related]
10. Variant GPI structure in relation to membrane-associated functions of a murine folate receptor.
Wang X; Jansen G; Fan J; Kohler WJ; Ross JF; Schornagel J; Ratnam M
Biochemistry; 1996 Dec; 35(50):16305-12. PubMed ID: 8973205
[TBL] [Abstract][Full Text] [Related]
11. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.
Behrendt N; Rønne E; Ploug M; Petri T; Løber D; Nielsen LS; Schleuning WD; Blasi F; Appella E; Danø K
J Biol Chem; 1990 Apr; 265(11):6453-60. PubMed ID: 2156852
[TBL] [Abstract][Full Text] [Related]
12. Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells.
Glass WF; Kreisberg JI; Troyer DA
Am J Physiol; 1993 Mar; 264(3 Pt 2):F532-9. PubMed ID: 8384415
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
[TBL] [Abstract][Full Text] [Related]
14. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
Olson D; Pöllänen J; Høyer-Hansen G; Rønne E; Sakaguchi K; Wun TC; Appella E; Danø K; Blasi F
J Biol Chem; 1992 May; 267(13):9129-33. PubMed ID: 1315748
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
Reuning U; Bang NU
Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
[TBL] [Abstract][Full Text] [Related]
16. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
Behrendt N; Ploug M; Patthy L; Houen G; Blasi F; Danø K
J Biol Chem; 1991 Apr; 266(12):7842-7. PubMed ID: 1850423
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol glycan formation and utilization by the ciliate Tetrahymena mimbres.
Pak Y; Ryals PE; Thompson GA
J Biol Chem; 1991 Aug; 266(23):15054-9. PubMed ID: 1651318
[TBL] [Abstract][Full Text] [Related]
18. Expression of an anchored urokinase in the apical endothelial cell membrane. Preservation of enzymatic activity and enhancement of cell surface plasminogen activation.
Lee SW; Kahn ML; Dichek DA
J Biol Chem; 1992 Jun; 267(18):13020-7. PubMed ID: 1535628
[TBL] [Abstract][Full Text] [Related]
19. An internally positioned signal can direct attachment of a glycophospholipid membrane anchor.
Caras IW
J Cell Biol; 1991 Apr; 113(1):77-85. PubMed ID: 1706725
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of the cleavage/attachment site of phosphatidylinositol-glycan-anchored membrane proteins determined by site-specific mutagenesis at Asp-484 of placental alkaline phosphatase.
Micanovic R; Gerber LD; Berger J; Kodukula K; Udenfriend S
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):157-61. PubMed ID: 2153284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
